For the Inventor, By the Inventor

Enter inventor name

San Carlos, CA, United States of America

Benjamin Spink

USPTO Granted Patents = 15 (Patent Applications = 25)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 10 (Patent Applications = 16)

Average Co-Inventor Count = 7.3

ph-index = 10

Forward Citations = 239(Granted Patents)

Company Filing History:

Amunix Operating Inc.

Amunix Pharmaceuticals, Inc

Bioverativ Therapeutics Inc.

Years Active: 2014-2024

Loading Chart...

Loading Chart...

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12071456 - Extended recombinant polypeptides and compositions comprising same (2024-08-27),

2. 10961287 - Extended recombinant polypeptides and compositions comprising same (2021-03-30),

3. 10870874 - Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same (2020-12-22),

4. 10421798 - Factor VIII compositions and methods of making and using same (2019-09-24),

5. 9976166 - Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same (2018-05-22),

6. 9926351 - Extended recombinant polypeptides and compositions comprising same (2018-03-27),

7. 9849188 - Growth hormone polypeptides and methods of making and using same (2017-12-26),

8. 9758776 - Coagulation factor IX compositions and methods of making and using same (2017-09-12),

9. 9376672 - Coagulation factor IX compositions and methods of making and using same (2016-06-28),

10. 9371369 - Extended recombinant polypeptides and compositions comprising same (2016-06-21),

11. 9249211 - Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same (2016-02-02),

12. 9168312 - Growth hormone polypeptides and methods of making and using same (2015-10-27),

13. 9062299 - Coagulation factor IX compositions and methods of making and using same (2015-06-23),

14. 8716448 - Coagulation factor VII compositions and methods of making and using same (2014-05-06),

15. 8673860 - Extended recombinant polypeptides and compositions comprising same (2014-03-18),

Title: The Innovations of Benjamin Spink

Introduction

Benjamin Spink is a notable inventor based in San Carlos, California. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant polypeptides. With a total of 15 patents to his name, Spink's work has the potential to impact various medical treatments.

Latest Patents

Among his latest patents is the invention of extended recombinant polypeptides and compositions comprising the same. This invention relates to compositions that include biologically active proteins linked to extended recombinant polypeptides (XTEN). It also encompasses isolated nucleic acids encoding these compositions, as well as vectors and host cells that contain them. The methods developed using these compositions aim to treat glucose-related diseases, metabolic diseases, coagulation disorders, and growth hormone-related disorders and conditions.

Career Highlights

Throughout his career, Benjamin Spink has worked with prominent companies in the biotechnology sector, including Amunix Operating Inc. and Amunix Pharmaceuticals, Inc. His expertise in recombinant technology has positioned him as a key player in the industry.

Collaborations

Spink has collaborated with notable professionals in his field, including Volker Schellenberger and Joshua A. Silverman. These collaborations have further enhanced his research and development efforts.

Conclusion

Benjamin Spink's innovative work in biotechnology, particularly in the area of recombinant polypeptides, showcases his dedication to advancing medical science. His contributions have the potential to lead to significant improvements in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…